{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:52:40Z","timestamp":1787014360516,"version":"build-2736575974"},"reference-count":99,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peripheral T\u2010cell lymphomas (PTCL) represent a heterogeneous disease group accounting for 10% of non\u2010Hodgkin lymphomas. PTCL patients have typically poorer outcomes compared with aggressive B\u2010cell lymphomas. However, such outcomes are heavily dependent on subtype. Although anthracycline\u2010based regimens such as cyclophosphamide, doxorubicin, vincristine and prednisone remain the standard first\u2010line treatment for most aggressive PTCL, there are important variations including incorporation of novel agents, use of radiotherapy and judicious consideration of stem cell transplantation. Relapsed or refractory disease represents a significant area of unmet need where chemotherapy intensification has limited efficacy and novel agents such as brentuximab vedotin and pralatrexate provide additional opportunities for attainment of remission and potential stem cell transplant. In the future, pre\u2010therapy prognostic biomarkers including genomic characterisation, may aid in risk stratification and help guide initial patient management to improve survival. There is an urgent need to understand better the pathogenesis of PTCL to facilitate novel drug combinatorial approaches to improve survival. This position statement represents an evidence\u2010based synthesis of the literature for application in Australian and New Zealand practice.<\/jats:p>","DOI":"10.1111\/imj.15595","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T18:16:42Z","timestamp":1634753802000},"page":"1806-1817","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis, management and follow up of peripheral T\u2010cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance"],"prefix":"10.1111","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-8496","authenticated-orcid":false,"given":"Greg","family":"Hapgood","sequence":"first","affiliation":[{"name":"Princess Alexandra Hospital  Brisbane Queensland Australia"},{"name":"University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Latimer","sequence":"additional","affiliation":[{"name":"The Canberra Hospital  Canberra Australian Capital Territory Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-456X","authenticated-orcid":false,"given":"Sze Ting","family":"Lee","sequence":"additional","affiliation":[{"name":"Olivia Newton John Cancer Research Institute, Austin Health  Melbourne Victoria Australia"},{"name":"University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryone","family":"Kuss","sequence":"additional","affiliation":[{"name":"Flinders University  Adelaide South Australia Australia"},{"name":"Flinders Medical Centre  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lade","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W. D.","family":"Tobin","sequence":"additional","affiliation":[{"name":"Mater Health  Brisbane Queensland Australia"},{"name":"Mater Research Institute, University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Purtill","sequence":"additional","affiliation":[{"name":"University of Western Australia  Perth Western Australia Australia"},{"name":"Fiona Stanley Hospital  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda A.","family":"Campbell","sequence":"additional","affiliation":[{"name":"University of Melbourne  Melbourne Victoria Australia"},{"name":"Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[{"name":"University of Melbourne  Melbourne Victoria Australia"},{"name":"Peter MacCallum Cancer Centre  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-2559","authenticated-orcid":false,"given":"Eliza A.","family":"Hawkes","sequence":"additional","affiliation":[{"name":"Olivia Newton John Cancer Research Institute, Austin Health  Melbourne Victoria Australia"},{"name":"University of Melbourne  Melbourne Victoria Australia"},{"name":"Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Shortt","sequence":"additional","affiliation":[{"name":"Monash University  Melbourne Victoria Australia"},{"name":"Monash Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Radeski","sequence":"additional","affiliation":[{"name":"University of Western Australia  Perth Western Australia Australia"},{"name":"Sir Charles Gairdner Hospital  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"e_1_2_14_2_1","volume-title":"WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2017"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3647"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2345"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000188"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15860"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-531509"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2872"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2873"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-644591"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.767901"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0494-8"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.6327"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15258"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404306"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02693-z"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_2_14_24_1","first-page":"1067","article-title":"A phase III comparison of CHOP vs m\u2010BACOD vs ProMACE\u2010CytaBOM vs MACOP\u2010B in patients with intermediate or high\u2010grade non\u2010Hodgkin's lymphoma: preliminary results of SWOG\u20108516 (Intergroup 0067), the national high priority lymphoma study","volume":"315","author":"Fisher R","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-573089"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S189825"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017010819"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu443"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1516873"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08329.x"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30039-5"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32984-2"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134398"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0469-9"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq635"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.816700"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0838-5"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134440"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-310342"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.08.015"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1842398"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13202"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.607145"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv201"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.01.009"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.07.007"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.02.001"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.01.006"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.05.013"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0838-5"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2719"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.63"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31861"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx787"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010387"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0053"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.07.027"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.64_2629"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.186577"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-780049"},{"key":"e_1_2_14_62_1","first-page":"1","article-title":"Retreatment with brentuximab vedotin in patients with CD30\u2010positive hematologic malignancies","volume":"7","author":"Bartlett NL","year":"2014","journal-title":"J Haematol Oncol"},{"key":"e_1_2_14_63_1","first-page":"1567","article-title":"Hyperphosphorylation of a novel 80 kDa protein\u2010tyrosine kinase similar to Ltk in a human Ki\u20101 lymphoma cell line, AMS3","volume":"9","author":"Shiota M","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt378"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1312379"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.0188"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25463"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2705"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.4882.4882"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13340"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1306642"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1612061"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-542142"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.939"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000187"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-840538"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806737"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001285"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601137658"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011144911781"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001852"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.6541"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26629"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-431460"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx684"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127811"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1811864"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14879"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2136-7"},{"key":"e_1_2_14_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-307454"},{"key":"e_1_2_14_92_1","first-page":"1","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T\u2010cell lymphoma","volume":"11","author":"Li X","year":"2018","journal-title":"J Haematol Oncol"},{"key":"e_1_2_14_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-756841"},{"key":"e_1_2_14_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231324"},{"key":"e_1_2_14_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh427"},{"key":"e_1_2_14_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199509000-00012"},{"key":"e_1_2_14_97_1","first-page":"191","article-title":"A single\u2010center report on clinical features and treatment response in patients with intestinal T cell non\u2010Hodgkin's lymphomas","volume":"16","author":"Novakonic BJ","year":"2006","journal-title":"Oncol Rep"},{"key":"e_1_2_14_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.795"},{"key":"e_1_2_14_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32833310fa"},{"key":"e_1_2_14_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000258"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15595","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.15595","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:38:08Z","timestamp":1692657488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.15595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1111\/imj.15595"],"URL":"https:\/\/doi.org\/10.1111\/imj.15595","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2021-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}